PUBLISHER: Marketdata LLC | PRODUCT CODE: 1548203
PUBLISHER: Marketdata LLC | PRODUCT CODE: 1548203
Fully 70% of Americans are estimated to experience insomnia symptoms or sleep disorders, such as sleep apnea. There are now an estimated 4,500 "sleep labs" or "centers" in the United States, that perform sleep studies and design treatment programs for insomniacs and those with sleep apnea.
Sleep centers were hit hard by the pandemic as they shifted to less costly at-home tests and telemedicine. However, the CPAPs market has grown strongly.
As obesity rates climb and Americans age, more people are developing sleep apnea and other sleep disorders. Plus, stressors related to inflation, politics, the pandemic and last recession are resulting in more sleepless nights for Americans.
This Marketdata study examines the sleep disorders treatment market. The report includes extensive sleep lab metrics (avg. revenues, patient volumes, bed counts, fees, more), $ market size (sleep center revenues, CPAP sales) from 1995-2023, with 2024 and 2028 Forecasts, patient demographics, in-depth competitor profiles, analysis of market nature & structure, history and evolution, reimbursement issues and the effect of Medicare rulings regarding home testing. Sleep technician salaries, regional market potentials, state data on sleep study costs.
Company profiles for: ResMed, Respironics, SleepMed, Sleep Holdings, MedBridge Healthcare, Novasom. Koala Centers, others. Data/surveys from the National Sleep Foundation, American Society of Sleep Medicine, Sleep Review, brokerage firms, CDC, Centers for Medicare Services, etc.